VSYM View Systems Inc.

Medical Therapeutics Opening New Clinic with Existing Patient Database in Pittsburgh Medical Complex

Medical Therapeutics Opening New Clinic with Existing Patient Database in Pittsburgh Medical Complex

PITTSBURGH, PA, July 26, 2018 (GLOBE NEWSWIRE) -- View Systems, Inc. (VSYM) today announced that its new medical division, Medical Therapeutics, a concierge medical service providing sexual healthcare, is opening a new medical facility in the Jonnet Bulding in Monroeville, an established up-scale suburb of Pittsburgh, PA. This new office is on 4099 William Penn Hwy. Suite 203, in the heart of Pittsburgh’s medical centers.  

The Company expects this clinic location to grow rapidly by taking advantage of easy access, affluent clients and a high demand for the clinic’s procedures and services.  The former clinic was generating close to $ 2 Million ($1.8M) in revenue prior to closing two years ago.  

William Kelly, Director of Operations, states, "Medical Therapeutics’ marketing division has been actively calling patients that are anxious to continue their therapy. Primary Care Physicians (PCP) in this area are already referring their patients with ED and other male hormonal issues to this new facility.  We are using this location to centralize drug inventory control, patient follow-up and outpatient support.”  

Medical Therapeutics has a select variety of highly effective procedures.  The Company plans to continue to expand its product offerings to satisfy the needs of their patients by offering procedures that are growing the clinic business while enhancing shareholder value.  The success of the Maryland office has allowed for a seamless launch of the Pennsylvania medical center to capitalize on the Company’s existing profitable business model. We are continuing the Baltimore clinic and adding patients as a satellite location with critical infrastructure support from the Pittsburgh clinic. 

About View Systems/Medical Therapeutics:

View Systems’ subsidiary Medical Therapeutics is opening medical clinics offering a variety of specialized procedures to appropriate patient demographics. 

View Systems Inc. continues to provide security and surveillance products to law enforcement facilities such as correctional institutions as well as to government agencies, schools, courthouses, event and sports venues, the military, and commercial businesses. 



View Systems
410-242-8439


Medical Therapeutics
410-449-3200  
EN
26/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on View Systems Inc.

 PRESS RELEASE

View Systems, Inc. (OTC: VSYM) and Ultimate Sports, Inc. (OTC: USPS) A...

View Systems, Inc. (OTC: VSYM) and Ultimate Sports, Inc. (OTC: USPS) Announce Plans to Issue Shares in USPS to VSYM Shareholders of Record as of June 30, 2022. Ultimate Sports, Inc. plans to acquire Sannabis S.A.S., a licensed medical marijuana Company in Colombia. For every VSYM share held, holder will receive .002 shares of USPS. Baltimore-USA, Barranquilla-Colombia, July 01, 2022 (GLOBE NEWSWIRE) -- View Systems, Inc. (OTC: ), the developer of the award winning ViewScan Concealed Weapons Detection and Asset Control System, with over 500 installations in schools, government buildings...

 PRESS RELEASE

View Systems, Inc.’s (VSYM) Sannabis Announces New Product to Supply t...

View Systems, Inc.’s (VSYM) Sannabis Announces New Product to Supply the Food and Beverage Industry with Cannabis Flavorings Full of Terpenes and Flavonoids to Enhance a Products Essence and Therapeutic Value Sannabis recently announced approvals by an Inspector from Colombia’s Ministry of Agriculture of their Seed Bank Facilities in anticipation of the Issuance of a coveted Cannabis Seed Use License. Cali, Colombia, April 20, 2021 (GLOBE NEWSWIRE) -- View Systems, Inc.’s (OTC:), Sannabis S.A.S. (the “Company”), a Colombian cannabis company, announces the development of a new product to ...

 PRESS RELEASE

View Systems, Inc.’s (VSYM) Sannabis Announces APPROVALS of their Seed...

View Systems, Inc.’s (VSYM) Sannabis Announces APPROVALS of their Seed Bank Facilities by Inspector from Colombian Institute of Agriculture (ICA) for the Issuance of a Coveted Cannabis Seed Use License in Colombia. Sannabis received two approvals, one for registration as an entity to conduct Agronomic Evaluation Studies (PEA), and another for registration as a producer of selected seeds. Cali, Colombia, April 15, 2021 (GLOBE NEWSWIRE) -- View Systems, Inc.’s (OTC:), Sannabis S.A.S. (the “Company”) announces the approval by an inspector from the Colombian Institute of Agriculture (ICA) of...

 PRESS RELEASE

View Systems, Inc. (VSYM) Announces Declaration of Dividend of View Sy...

View Systems, Inc. (VSYM) Announces Declaration of Dividend of View Systems International, Inc. to Shareholders of Record on February 19, 2021. Company continues to receive inquiries from existing customers wanting to upgrade their ViewScan Concealed Weapons Detection units to include thermal detection. Baltimore, Feb. 09, 2021 (GLOBE NEWSWIRE) -- View Systems, Inc. (OTC:), the developer of the award winning ViewScan Concealed Weapons Detection and Asset Control System, with over 500 installations in government buildings and military bases around the World, announces a declaration of div...

 PRESS RELEASE

View Systems, Inc. (VSYM) to Declare Dividend of Shares in Operating E...

View Systems, Inc. (VSYM) to Declare Dividend of Shares in Operating Entity, View Systems International, Inc., to spin out their ViewScan Technology and Focus on Developing their South American Cannabis Operations.  Sannabis was recently issued a Fabrication License by the Colombian Government and anticipates soon the approval of Cultivation and Seed Use Licenses. Baltimore, MD, Dec. 11, 2020 (GLOBE NEWSWIRE) -- View Systems, Inc. (OTC:) will declare a dividend of shares in wholly owned subsidiary, View Systems International, Inc. (VSII), to shareholders on a record date yet to be determ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch